e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Treatment of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiac output measured by rebreathing nitrous oxide for the follow-up of patient with pulmonary hypertension
G. Deboeck, R. McKenzie Ross, J. Pepke-Zaba (Papworth, United Kingdom)
Source:
Annual Congress 2011 - Treatment of pulmonary hypertension
Session:
Treatment of pulmonary hypertension
Session type:
Thematic Poster Session
Number:
2390
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Deboeck, R. McKenzie Ross, J. Pepke-Zaba (Papworth, United Kingdom). Cardiac output measured by rebreathing nitrous oxide for the follow-up of patient with pulmonary hypertension. Eur Respir J 2011; 38: Suppl. 55, 2390
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
The effect of inhaled nitric oxide on the cardiac performance in patients with hypoxic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Is cardiac output assessed by inert gas rebreathing technique predictive of mortality in pulmonary hypertension?
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Prognostic value of end-tidal partial pressure of carbon dioxide during cardiopulmonary exercise test in pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Haemodynamic testing in primary pulmonary hypertension - effects of nitric oxide, iloprost and oxygen
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001
Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Arterial stiffness in COPD patients is associated with hypoxemia and plasma nitric oxide level
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders
Source: Eur Respir J 2002; 19: 664-671
Year: 2002
Non-invasive measurement of stroke volume using an inert gas rebreathing device in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2011; 39: 119-124
Year: 2012
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2012; 39: 119-124
Year: 2012
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Comparison of single-breath and tidal breathing exhaled nitric oxide levels in infants
Source: Eur Respir J 2004; 23: 369-372
Year: 2004
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
Feasibility of home treatment with inhaled nitric oxide for primary pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002
Relationship between basal and nitroglycerin (GTN)-induced exhaled nitric oxide (eNO) and oxygenation parameters in ventilated patients undergoing cardiopulmonary bypass (CPB)
Source: Eur Respir J 2004; 24: Suppl. 48, 264s
Year: 2004
The relationship of systolic pulmonary arterial pressure with pulmonary function test and the fractional exhaled nitric oxide level in Kyrgyz population.
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2007; 29: 944-950
Year: 2007
Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept